US › Healthcare

Mangoceuticals, Inc. Common Stock (MGRX)

US · Healthcare · Health Information Services

$0.46-14.55%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$67,864

Revenue YoY

-37.9%

Net profit

$-3.4M

Profit YoY

+29.7%

EPS

$-0.22

Net margin

-5,014.6%

Key statistics

Market cap

$9.6M

Forward P/E

0.0

P/B

0.71

Book value

$0.79

EPS (TTM)

$-1.27

52-week high

$2.75

52-week low

$0.16

50-day MA

$0.41

200-day MA

$0.73

Beta

2.28

Shareholding

Insiders

10.04%

Institutions

4.97%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.13%
Ikarian Capital, LLC	0.80%
Vanguard Capital Management, LLC	0.72%
Jane Street Group LLC	0.42%
Virtu Financial LLC	0.36%
Vanguard Fiduciary Trust Co	0.33%
BOOTHBAY FUND MANAGEMENT, LLC	0.22%
Northern Trust Corp	0.22%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Mangoceuticals, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.